Stock data

永昕 (4726)

永昕 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$116.38M, up 393.3% from a year earlier. EPS over the last four quarters totals -NT$1.84.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 永昕 in Insightr